Please login to the form below

Not currently logged in
Email:
Password:

TMC435

This page shows the latest TMC435 news and features for those working in and with pharma, biotech and healthcare.

Janssen buys hepatitis C candidate from GSK

Janssen buys hepatitis C candidate from GSK

The company plans to start trials combining GSK2336805 with its non-nucleoside polymerase inhibitor TMC647055 and simeprevir (TMC435) - an NS3/4A protease inhibitor developed with Sweden's Medivir.

Latest news

  • BMS and Vertex partner on oral hepatitis treatment BMS and Vertex partner on oral hepatitis treatment

    BMS' daclatasvir is an NS5A replication complex inhibitor that is already under investigation in combination with several other therapies, including Tibotec's NS3 protease inhibitor simeprevir (formerly known as TMC435) and

  • Merck and Roche team up for hepatitis C studies

    BMS 650032, and Johnson &Johnson/Tibotec's TMC435, all of which are in phase III testing.

  • BMS and Tibotec plan all-oral hepatitis C regimen

    The therapy would combine BMS' daclatasvir (BMS-790052), an NS5A replication complex inhibitor, with Tibotec's NS3 protease inhibitor TMC435, which is partnered with Medivir. ... Tibotec is currently conducting two phase II trials for TMC435 in

  • Medivir buys BioPhausia

    Medivir says that the acquisition would provide it with a well-established commercial platform from which to launch its hepatitis C drug TMC435, which should be introduced on to the market ... of TMC435.”.

More from news
Approximately 0 fully matching, plus 5 partially matching documents found.

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Empowering Strategic Performance Ltd

OUR GOAL: To help clients Metamorph™ Science into Action that changes healthcare to improve the lives of patients. Empowering Strategic...

Latest intelligence

InSite Events™ National Pharma Meeting: A Customer Story
How our client leveraged Impetus Digital’s white-glove service, 360° coverage and care, and award-winning InSite Events™ platform to successfully transfer their annual national meeting online....
Fear or encouragement, which is best to drive behaviour change?
The communications industry depends on fear of the perceived loss of something, in order to create the hope found in a product benefit. But, if if left too long unchecked,...
The unheard, unseen, and uncorrected effects of COVID-19
The disproportionate effects of the pandemic have been highlighted amongst ethnic minorities, so is it likely that ethnic minorities will be more worried about participating? And could this exacerbate inequalities...

Infographics